Healthia (ASX: HLA) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Healthia Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Healthia (ASX: HLA)
Latest News
Small Cap Shares
2 little known small cap ASX shares to buy
Share Market News
Healthia (ASX:HLA) share price on watch after 78% profit growth
Growth Shares
2 growing small cap ASX shares to buy
Share Gainers
Here's why the Healthia (ASX:HLA) share price is racing higher
⏸️ ASX Shares
3 exciting small cap ASX shares rated as buys
Share Market News
Healthia (ASX:HLA) share price on watch after acquisitions update
⏸️ Investing
5 top ASX shares picked by analysts
Share Gainers
ASX small cap expands to North America, share price up 7.5%
Share Market News
Analysts pick top ASX stocks for the quarter
Share Market News
This new share could be one to watch with its acquisition strategy
Share Market News
How these IPOs fared 1 week later
Frequently Asked Questions
-
Yes, Healthia has historically paid two fully franked dividends a year.
-
Healthia has generally paid its shareholder dividends in March and September/October.
-
Healthia Ltd listed on the ASX on 11 September 2018.
Dividend Payment History Data provided by Morningstar.
Ex-Date | Amount | Franking | Type | Payable |
---|---|---|---|---|
03 Mar 2023 | $0.0200 | 100.00% | Interim | 27 Mar 2023 |
03 Mar 2022 | $0.0200 | 100.00% | Interim | 24 Mar 2022 |
07 Sep 2021 | $0.0250 | 100.00% | Final | 27 Oct 2021 |
02 Mar 2021 | $0.0200 | 100.00% | Interim | 23 Mar 2021 |
08 Sep 2020 | $0.0200 | 100.00% | Final | 28 Sep 2020 |
HLA ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
---|---|---|---|---|---|
YesNo |
About Healthia
Healthia Ltd (ASX: HLA) is an Australian holding company that operates allied health services, including podiatry, optometry, and physiotherapy. The company owns and operates My FootDr podiatry clinics, Allsports physiotherapy and sports medicine clinics, iOrthotics, Optical Co optometry stores, as well as other health brands.
Healthia's podiatry division provides podiatry services and podiatry-related services including the manufacturing and sale of orthotics and other podiatry products. The company also operates Natural Fit Footwear retail stores.
The company's physiotherapy segment provides sports and general physiotherapy, specialty hand therapy services, and operates rehabilitation clinics.
In all, the company operates more than 30 allied health brands.
Healthia Ltd (ASX: HLA) was removed from the ASX Official List on 12 December 2023.
Director Transactions Data provided by Morningstar.
Date | Director | Type | Amount | Value | Notes |
---|---|---|---|---|---|
01 Dec 2023 | Colin Kangisser | Issued | 406,268 | $729,251 |
Conversion of securities.
|
01 Dec 2023 | Colin Kangisser | Exercise | 406,268 | $729,251 |
Conversion of securities.
|
01 Dec 2023 | Lisa Roach | Issued | 407,322 | $731,142 |
Conversion of securities.
|
01 Dec 2023 | Lisa Roach | Exercise | 407,322 | $731,142 |
Conversion of securities.
|
30 Nov 2023 | Wesley Coote | Issued | 1,173,750 | $2,106,881 |
Conversion of securities. As per announcement on 04-12-2023
|
30 Nov 2023 | Wesley Coote | Exercise | 1,173,750 | $2,106,881 |
Conversion of securities.
|
Directors & Management Data provided by Morningstar.
Name | Title | Start Date | Profile |
---|---|---|---|
Ms Lisa Jane Dalton | Non-Executive Director | May 2018 |
Ms Dalton is an experienced director, senior executive and company secretary with experience in the healthcare, medical, utilities, manufacturing, childcare, energy, mining and construction sectors. She has experience in leading teams responsible for strategy, governance, risk management, human resources, communication, stakeholder relations and program management. Lisa has participated in 4 ASX listings in the past 5 years. Lisa has practical experience in fit for purpose governance, risk management, strategic planning and motivating teams to find solutions to complex issues. She is Member of Risk Committee.
|
Dr Glen Frank Richards | Non-Executive ChairmanNon-Executive Director | May 2018 |
Mr Richards is a veterinary surgeon. He has spent over 20 years building a multimillion-dollar integrated pet care empire, which now operates more than 180 veterinary hospitals and 230 pet care retail stores in Australia and Animates in New Zealand. He is a member of Risk Committee.
|
Mr Wesley James Coote | Chief Executive OfficerManaging Director | Apr 2019 |
Mr Coote is the former Chief Financial Officer and Company Secretary of Greencross Ltd. Prior to Greencross, Wesley worked in Chartered Accounting where he provided business advice within the health sector, property sector and financial services industry. Wesley joined the Group in December 2015 as Chief Financial Officer and Company Secretary and was appointed Group Managing Director and Chief Executive Officer on 29 April 2019.
|
Mr Paul David Wilson | Non-Executive Director | May 2018 |
Mr Wilson was a co-founder, director and shareholder of Mammoth Pet Holdings Pty Ltd (Pet Barn) prior to the merger with Greencross Limited. Prior to founding Mammoth, Paul was the Chief Operating Officer of ShopFast (sold to Coles in 2003). Paul has worked in the retail industry for 26 years with roles including General Manager of Caltex/Boral JV, Vitalgas. He is Chairman of Risk Committee.
|
Mr Darren Stewart | Executive Director | May 2018 |
Mr Stewart is a registered podiatrist and in 2004 co-founded the My FootDr Business with Greg Dower. In 2015, Darren and Greg saw the opportunity to grow their network of clinics through the acquisition of podiatry clinics. Before merging with Balance Podiatry Group in December 2016. Darren provides strategic leadership and direction to the Feet & Ankles business division.
|
Mr Colin Jonathan Kangisser | Non-Executive Director | Nov 2020 |
Mr Kangisser is a registered optometrist with over 30 years optical experience. He founded, grew and exited multiple retail chains including Optic Express and Kays Optical prior to holding executive leadership positions with the OPSM Group and founding TOC in 2005.
|
Mrs Lisa Michelle Roach | Executive Director | Apr 2022 |
Mrs Roach was a founding partner in several of the Allsports Clinics and has over 29 years of experience in the allied health industry; she was also a qualified and practicing physiotherapist for 10 years. Mrs Roach has held an Executive role and been heavily involved and influential within Healthia since IPO. Her current role is Chief Operations and People Officer for Healthia's Bodies & Minds, Feet & Ankles divisions. Mrs Roach has held board positions on Healthia's subsidiary entities since IPO.
|
Ms Julia Murfitt | General CounselCompany Secretary | Feb 2022 |
-
|
Julia Murfitt | General CounselCompany Secretary |
-
|
Top Shareholders Data provided by Morningstar.
Name | Shares | Capital |
---|---|---|
Citicorp Nominees Pty Limited | 20,948,911 | 14.94% |
Hsbc Custody Nominees (Australia) Limited | 18,024,648 | 12.86% |
J P Morgan Nominees Australia Pty Limited | 11,317,234 | 8.07% |
Belaroo Pty Ltd | 6,963,607 | 4.97% |
Bridell Pty Limited | 5,134,628 | 3.66% |
Maximum (Nq) Pty Ltd | 4,923,299 | 3.51% |
Bnp Paribas Noms Pty Ltd | 3,812,058 | 2.72% |
Dlh Trading Pty Ltd | 3,495,465 | 2.49% |
Ubs Nominees Pty Ltd | 3,420,296 | 2.44% |
Jabez Fund Pty Ltd | 3,069,444 | 2.19% |
Rom Group Pty Ltd | 2,373,267 | 1.69% |
Maximum (Nq) Pty Ltd (ii) | 1,815,670 | 1.30% |
Mr Milton Zevi Levine | 1,625,025 | 1.16% |
Willeese Pty Limited | 1,547,383 | 1.10% |
HSBC Custody Nominees (Australia) Limited A/C 2 | 1,409,627 | 1.01% |
Pacific Custodians Pty Limited | 1,316,823 | 0.94% |
Gf & Lh Richards Super Pty Ltd | 1,177,808 | 0.84% |
National Nominees Limited | 1,078,424 | 0.77% |
Hgt Investments Pty Ltd | 982,800 | 0.70% |
Dpc Investments Pty Ltd | 967,317 | 0.69% |